Laryngeal chondrosarcoma is a rare entity, reportedly comprising less than 1% of all laryngeal tumors. Obtaining the necessary tissue for a histological examination can be difficult. Another difficult step is distinguishing a chondrosarcoma from a chondroma. This differentiation can be achieved through immunohistochemical analysis.
INTRODUCTION
Non-epidermoid cancers of the larynx like chondrosarcoma are an uncommon form of neoplasm, accounting for less than 1% of cancers of the larynx (1) , and about 0.1% of all neoplasms of thehead and neck region (2) . The etiology of the disease is unknown, although it is usually assumed to derive from disordered ossification of the laryngeal cartilage (3) (4) (5) .
We present the clinical and immunohistochemical analysis of a laryngeal chondrosarcoma, located on the cricoid cartilage, well differentiated and with low grade malignancy.
CASE REPORT
A 66 year-old male patient presented to our ENT Department with one year history of increasing dyspnea, stridor and weight loss. Indirect laringoscopy revealed a subglottic tumoral mass, obstructing 80% of its circumference. We performed urgent tracheotomy, under local anesthesia.
The direct microlaryngoscopy that we performed afterwards emphasizes a firm yellow-white subglottic tumor mass, located on the posterior wall of the cricoid. We collected biopsy from the tumor and we performed a histopathological and immunohistochemical examination.
After establishing the anatomopathological diagnosis of low-grade malignancy chondrosarcoma, we searched for methastatic lesions using CT scan, without finding any evidence of metastasis. We performed a total laryngectomy with primary pharyngeal reconstruction due to tumoral extension below the lower edge of the cricoid cartilage. Postoperative evolution was favorable, without any complications or relapse.
The entire larynx was delivered to the Anatomopathological Department of the hospital for histological and immunohistochemical analysis. Macroscopic appearance -it was a unique whitish polypoid, sessile tumor, with variable consistency, gelatinous areas, in the long axis diameter of 3 cm, which is located on the subglottis, under the right vocal cord.
The tissues were prepared using standard technique of paraffin inclusion through the following stages: fixation in 10% buffered formalin, washing in 80% alcohol, dehydration by successive alcohol baths, clarification and paraffin embedding. For staining we used the classic Hematoxylin-Eosin (HE) technique.
The immunohistochemical method was based on soluble immunoenzymatic complexes -LSAB/HRP (Labeled Streptavidin Biotin) method and the following antibodies: S100, alphasmooth muscle actin, vimentin, Ki-67. Necrosis and atypical mitosis were absent. Recent findings indicate that chondroma and chondrosarcoma of the larynx are closely related, either synchronously (areas of both tumor types within the same lesion) or metachronously (malignant transformation of chondroma over time) (11) . It is important to perform an immunohistochemical analysis, since it is the only one able to distinguish between the two tumors.The IHC profile for conventional chondrosarcoma is characterized by diffuse positivity for Vimentin and S100 expression, low Ki-67 proliferation index, and an α-actin which can be positive in rare tumor cells (12) . S100 -It is a low molecular weight protein and cytoplasmatic marker for histiocytes, chondrocytes, lipocytes, striated muscle, Schwann cells and also glial and myoepithelial cells. In our case, the marker was positive, having a diffuse disposal in tumoral chondrocytes (Fig. 2) . Smooth muscle actin (α-actin) -It is a cytoplasmatic marker for smooth muscle cells, myofibroblasts, myoepithelial and endothelial cells. In our case, it was intensely positive in isolated tumor cells (Fig. 3) .
Vimentin -It is a mesenchymal cytoplasmatic marker for fibroblasts, muscle cells, chondroblasts, osteoblasts, endothelial cells, hematopoietic cells. In our case, the tumor cells had an intense and diffuse response for vimentin (Fig. 4) . Ki-67 -It is a nuclear marker expressed in phases G1, S, G2 and M of the cell cycle. In our case, Ki-67 was rarely positive on tumor cells (≤ 2%) (Fig. 5) . The recommended treatment of laryngeal chondrosarcomas is conservative surgical excision, if possible (12, 13) . Total laryngectomy is recommended when laryngeal chondrosarcoma develops from cricoid cartilage, making the preservation of larynx functions impossible (14) and in cases of relapse (15) . In our case, we opted for total laryngectomy.
The five-year survival rate and tendency of metastasis depends on the differantion grade of the tumor. Low grade chondrosarcoma has a 90% five-year survival rate and shows no tendency of metastasis (16) . In our case, the patient is still alive four years after his surgical intervention. 
